Author: Gwon, Yong-Dae; Strand, Mårten; Lindqvist, Richard; Nilsson, Emma; Saleeb, Michael; Elofsson, Mikael; Överby, Anna K.; Evander, Magnus
Title: Antiviral Activity of Benzavir-2 against Emerging Flaviviruses Document date: 2020_3_22
ID: 0ym40eki_46
Snippet: Members of the flavivirus genus cause severe morbidity and mortality to mankind worldwide. Since benzavir-2 displayed potent activity against the rZIKV-ZsGreen vector and two wt ZIKV lineages, we assessed if other flaviviruses of medical importance were inhibited. Vero B4 cells were infected with six members of the flavivirus genus (ZIKV, TBEV, WNV, JEV, YFV, or DENV2) in the presence of benzavir-2 (2.5 µM) or ribavirin (50 µM). The supernatant.....
Document: Members of the flavivirus genus cause severe morbidity and mortality to mankind worldwide. Since benzavir-2 displayed potent activity against the rZIKV-ZsGreen vector and two wt ZIKV lineages, we assessed if other flaviviruses of medical importance were inhibited. Vero B4 cells were infected with six members of the flavivirus genus (ZIKV, TBEV, WNV, JEV, YFV, or DENV2) in the presence of benzavir-2 (2.5 µM) or ribavirin (50 µM). The supernatant was harvested 24 h or 48 h post-infection and titers were determined by focus-forming assay. Ribavirin showed an approximately ten-fold significant reduction for four of the flaviviruses, ZIKV, TBEV, YFV, and DENV2 (viral titer reduction: ZIKV = 1.0 × 10 1 ; TBEV = 1.2 × 10 1 ; YFV = 0.9 × 10 1 ; and DENV2 = 1.1 × 10 1 ), while no significant activity was detected against JEV and WNV ( Figure 6 ). Strikingly, 2.5 µM of benzavir-2 treatment showed a ≈ 10 3 -10 5 -fold significant reduction of infection in all six flaviviruses analyzed (viral titer reduction in: ZIKV = 1.0 × 10 3 ; TBEV = 7.5 × 10 3 ; WNV = 2.2 × 10 4 ; JEV = 7.5 × 10 3 ; YFV = 1.5 × 10 3 ; and DENV2 = 5.6 × 10 4 ). These results confirmed the potent broad-spectrum activity of benzavir-2.
Search related documents:
Co phrase search for related documents- broad spectrum activity and medical importance: 1, 2, 3
- broad spectrum activity and mortality severe morbidity: 1, 2
- broad spectrum activity and post infection: 1, 2, 3, 4, 5, 6
- broad spectrum activity and potent activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- broad spectrum activity and potent broad spectrum activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- broad spectrum activity and rzikv ZsGreen vector: 1
- broad spectrum activity and severe morbidity: 1, 2
- broad spectrum and mankind mortality severe morbidity: 1
- broad spectrum and medical importance: 1, 2, 3, 4, 5, 6, 7, 8
- broad spectrum and mortality severe morbidity: 1, 2, 3, 4, 5
- broad spectrum and post infection: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- broad spectrum and potent activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- broad spectrum and potent broad spectrum activity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
- broad spectrum and rzikv ZsGreen vector: 1
- broad spectrum and severe morbidity: 1, 2, 3, 4, 5, 6, 7
- mankind mortality severe morbidity and post infection: 1
- mankind mortality severe morbidity and potent activity: 1
- mankind mortality severe morbidity and potent broad spectrum activity: 1
- mankind mortality severe morbidity and rzikv ZsGreen vector: 1
Co phrase search for related documents, hyperlinks ordered by date